Manufacturers Life Insurance Company, The Lyell Immunopharma, Inc. Transaction History
Manufacturers Life Insurance Company, The
- $103 Billion
- Q1 2024
A detailed history of Manufacturers Life Insurance Company, The transactions in Lyell Immunopharma, Inc. stock. As of the latest transaction made, Manufacturers Life Insurance Company, The holds 483,451 shares of LYEL stock, worth $701,003. This represents 0.0% of its overall portfolio holdings.
Number of Shares
483,451
Previous 464,325
4.12%
Holding current value
$701,003
Previous $900,000
19.78%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding LYEL
# of Institutions
128Shares Held
144MCall Options Held
0Put Options Held
5.9K-
Mwg Management Ltd. Washington, DC20.2MShares$29.2 Million33.29% of portfolio
-
Apoletto LTD Washington, DC15.1MShares$21.9 Million42.56% of portfolio
-
Orland Properties LTD Washington, DC15.1MShares$21.9 Million19.02% of portfolio
-
Black Rock Inc. New York, NY13.9MShares$20.1 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.4MShares$19.4 Million0.0% of portfolio
About Lyell Immunopharma, Inc.
- Ticker LYEL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 247,824,992
- Market Cap $359M
- Description
- Lyell Immunopharma, Inc., a T cell reprogramming company, engages in developing T cell therapies for patients with solid tumors. The company develops therapies using technology platforms, such as Gen-R, an ex vivo genetic reprogramming technology to overcome T cell exhaustion; and Epi-R, an ex vivo epigenetic reprogramming technology to generate...